Inositol for the prevention of gestational diabetes: a systematic review and meta-analysis of randomized controlled trials.

Amerigo VitaglianoGabriele SacconeErich CosmiSilvia VisentinFrancesco DessoleGuido AmbrosiniVincenzo Berghella

Published in: Archives of gynecology and obstetrics (2018)

ISLs administration during pregnancy appears to be safe and may represent a novel strategy for GDM prevention. In particular, the double administration of MYO 2 g per day may improve the glycemic homeostasis and may reduce GDM rate and preterm delivery rate.

Keyphrases

type diabetes
low birth weight
gestational age
metabolic syndrome
adipose tissue